EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines

Juan Sebastian Quintero-Barbosa, Yufeng Song, Frances Mehl iD, Shubham Mathur iD, Lauren Livingston iD, Peter D Kwong iD, Xiaoying Shen iD, David C Montefiori, Steven L Zeichner

Viruses · 2026

DOI: 10.3390/v18020209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Juan Sebastian Quintero-Barbosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV-1, HIV Envelope Protein gp41, HIV Infections. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Food and Agriculture, Ivy Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Killed Whole Cell Genome-Reduced Bacteria (KWC/GRB), a versatile vaccine platform, can produce very low cost, thermostable, easily manufactured vaccines expressing complex immunogens that include potent immunomodulators. This system supports iterative optimization through a Design–Build–Test–Learn (DBTL) workflow aimed at enhancing immunogenicity. We applied this approach to developing HIV-1 gp41 Membrane-Proximal External Region (MPER) vaccines using the scaffolded MPER antigen, 3AGJ, a recombinant heterologous protein engineered to mimic MPER structures recognized by broadly neutralizing monoclonal antibodies (bNAbs).

Methods

Five KWC/GRB vaccines expressing versions of 3AGJ were designed, including versions linked to immunomodulators and multimers of the immunogen. Display on the surface of the bacteria was evaluated by flow cytometry using the broadly neutralizing monoclonal antibody 2F5. Outbred HET3 mice were vaccinated intramuscularly, and MPER-specific antibody responses were assessed by ELISA and by the ability of the vaccines to induce neutralizing antibodies. Neutralization was measured against tier 1 and tier 2 HIV-1 pseudoviruses.

Results

All five vaccines were strongly expressed on the bacterial surface and induced clear MPER-specific antibody responses in every mouse. About 33% of the animals showed detectable HIV-1 neutralization.

Conclusions

These results demonstrate that a KWC/GRB-based scaffold-MPER (3AGJ) vaccine can elicit HIV-1 neutralizing antibodies in a subset of animals. Although further optimization will be required to improve the consistency and magnitude of neutralizing responses, the findings provide an initial validation of the concept. There are many strategies that can be used to enhance and extend immune responses induced by KWC/GRB vaccines that can be employed to yield improved anti-HIV-1 immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesHIV-1HIV Envelope Protein gp41HIV InfectionsAnimalsHIV AntibodiesMiceAntibodies, NeutralizingVaccines, InactivatedHumansFemaleAntibodies, MonoclonalNeutralization Tests

Stichwörter der Autor:innen

HIV-1 neutralizationHIV-1 vaccineMPERautotransportergenome-reduced bacteriakilled whole-cellsurface-antigen displayvaccine engineeringvaccine platform

Substanzen

AIDS VaccinesHIV AntibodiesHIV Envelope Protein gp41Antibodies, NeutralizingVaccines, InactivatedAntibodies, Monoclonalgp41 protein, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA.
  • Aaron Diamond AIDS Research Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
  • Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Surgery, Duke University, Durham, NC 27710, USA.
  • Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

ORCID-Profile: Frances Mehl, Shubham Mathur, Lauren Livingston, Peter D Kwong, Xiaoying Shen

Förderung

  • NIAID NIH HHS
  • National Institute of Food and Agriculture
  • Ivy Foundation
  • Wallace H. Coulter Foundation
  • Manning Fund for COVID-19 Research at the University of Virginia
  • Pendletone Laboratory for Pediatric Infectious Disease Research
  • NCI NIH HHS
  • Pendleton Laboratory Fund for Pediatric Infectious Disease Research

Zitieren

APA

Quintero-Barbosa, J. S., Song, Y., Mehl, F., Mathur, S., Livingston, L., Kwong, P. D., Shen, X., Montefiori, D. C., & Zeichner, S. L. (2026). HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines. Viruses. https://doi.org/10.3390/v18020209

Vancouver

Quintero-Barbosa JS, Song Y, Mehl F, Mathur S, Livingston L, Kwong PD, et al. HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines. Viruses. 2026. doi:10.3390/v18020209

BibTeX
@article{QuinteroBarbosa2026,
  author = {Quintero-Barbosa, Juan Sebastian and Song, Yufeng and Mehl, Frances and Mathur, Shubham and Livingston, Lauren and Kwong, Peter D and Shen, Xiaoying and Montefiori, David C and Zeichner, Steven L},
  title = {HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18020209}
}
Kostenlos starten →